Lucentis offers treatment alternative for diabetic retinopathy, trial finds.

Authors	Jacqui Wise
Journal	BMJ (Clinical research ed.) (BMJ) Vol. 351 Pg. h6145 (Nov 16 2015) ISSN: 1756-1833 [Electronic] England
PMID	26577167 (Publication Type: News, Comment)
Chemical References	Angiogenesis Inhibitors Ranibizumab
Topics	Angiogenesis Inhibitors (administration & dosage) Diabetic Retinopathy (drug therapy, surgery) Female Humans Light Coagulation (methods) Male Ranibizumab (administration & dosage) Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!